Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/6192
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWallington-Gates, Craig Thomasen
dc.contributor.authorMynott, R.L.en
dc.date.accessioned2024-08-08T03:22:00Z-
dc.date.available2024-08-08T03:22:00Z-
dc.date.issued2021-
dc.identifier.citationResearchSquare, 2021en
dc.identifier.urihttps://dora.health.qld.gov.au/qldresearchjspui/handle/1/6192-
dc.titlePrognostic and Therapeutic Biomarker Developments in Multiple Myelomaen
dc.typeArticleen
dc.identifier.doi10.21203/rs.3.rs-578394-
dc.identifier.scopus2-s2.0-85132490569-
dc.rights.holderCraig Wallington-Gatesen
dc.identifier.journaltitleResearchSquare-
dc.identifier.external135967590-
item.fulltextNo Fulltext-
item.openairetypeArticle-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
Appears in Sites:Queensland Health Publications
Sunshine Coast HHS Publications
Show simple item record

Page view(s)

398
checked on May 21, 2026

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.